Followers | 246 |
Posts | 49778 |
Boards Moderated | 63 |
Alias Born | 08/29/2007 |
Sunday, November 26, 2023 3:08:21 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent RYTM News
- Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology • GlobeNewswire Inc. • 04/29/2024 10:30:00 PM
- Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 • GlobeNewswire Inc. • 04/24/2024 08:01:00 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 04/16/2024 08:01:00 PM
- Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 03/11/2024 08:01:00 PM
- Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences • GlobeNewswire Inc. • 03/06/2024 09:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/29/2024 09:58:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:46:06 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/29/2024 09:44:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 09:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:01:26 PM
- Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan • GlobeNewswire Inc. • 02/22/2024 12:01:00 PM
- Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:02:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:01:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:00:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:00:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 11:14:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:49:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:47:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:46:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:45:18 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/09/2024 09:19:15 PM
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants • GlobeNewswire Inc. • 02/08/2024 09:01:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM